Those two substances are the two most commonly used chimeric monoclonal antibodies against TNF-α, which are used in clinical practice worldwide to treat inflammatory diseases such as RA, ankylosing spondylitis, psoriatic arthritis and Crohn disease [115,116]. Here, TNF is linked to rheumatoid arthritis.